The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.
about
The sub-optimal response to controlled ovarian stimulation: manageable or inevitable?Prevention of Ovarian Hyperstimulation Syndrome: A ReviewIndividualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practiceAnti-Müllerian hormone: ovarian reserve testing and its potential clinical implicationsPrognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocolLow-cost in vitro fertilization: current insights.Best practices for controlled ovarian stimulation in in vitro fertilizationThe Ideal Stimulation Protocol: Is There One?Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: A retrospective cohort study.Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review.How to personalize ovarian stimulation in clinical practicePerformance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay.Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.Reply: Is it necessary to recognize the sub-optimal responder.Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
P2860
Q26800627-3FA5D399-E1A3-4D4C-B5B8-D9F669AE343AQ26828442-26226D24-95AE-4DAB-8BA5-B4BAED62B88AQ26829747-14F3F127-E9AB-4D25-B9EE-49D7CB00393AQ28239980-6DD070C2-DD06-4E72-B3E1-FE012421E598Q33888265-0C177664-DB15-48EE-9DC5-5B12C75DF00BQ34110154-D3432BE2-FD6C-4264-97AA-43AEF7314C0FQ36233245-916B609D-B83D-4FC9-B055-9A5118D2BE8FQ36337216-88619D51-ABE0-45A8-AD9A-AD93526524AFQ37737306-7B1438CB-9FAB-4EBD-BAA8-07965BFC7490Q38968422-F2C9E194-683A-404D-B4CD-5F83A3E8286EQ41522319-B1FE0EF3-AA7E-4D97-BD01-51F822102535Q45877018-E234FCED-7F7A-4908-86EA-DBEDA906DA15Q47221797-D02A98F7-065E-43FE-A6EB-20BFFC771663Q47848951-6A8CDDB8-746A-458F-B158-98AD85F39EB8Q48566463-5867256E-E7B9-428E-A3F8-D42350187398Q48592002-49AEEF21-AB17-457E-B4FC-8DD01A34C1BBQ48605923-62B3EC88-5BED-4FC5-A702-0D7D56746AE3
P2860
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@ast
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@en
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@nl
type
label
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@ast
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@en
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@nl
prefLabel
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@ast
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@en
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@nl
P2093
P2860
P356
P1433
P1476
The OPTIMIST study: optimisati ...... A randomised controlled trial.
@en
P2093
Alexander V Sluijmer
Annemiek W Nap
Annemieke Hoek
Arie Verhoeff
Arne M van Heusden
Ben Willem J Mol
Carolien A M Koks
Cornelis B Lambalk
Egbert A Brinkhuis
Frank J M Broekmans
P2860
P2888
P356
10.1186/1472-6874-12-29
P577
2012-09-18T00:00:00Z
P5875
P6179
1027433885